Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary efficacy objective for this study is to evaluate the efficacy of MPDL3280A in patients with PD-L1−positive locally advanced or metastatic NSCLC, as measured by investigator-assessed ORR according to modified RECIST
Critère d'inclusion
- PD-L1-POSITIVE LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER